메뉴 건너뛰기




Volumn 54, Issue 17, 2009, Pages 1607-1608

Pre-Operative Cardiac Risk Assessment in Noncardiac Surgery. Are Natriuretic Peptides the Magic Bullet?

Author keywords

brain natriuretic peptide; perioperative myocardial infarction; perioperative risk

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

EID: 70349729929     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.06.029     Document Type: Editorial
Times cited : (14)

References (18)
  • 1
    • 0035807597 scopus 로고    scopus 로고
    • The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes
    • de Lemos J.A., Morrow D.A., Bentley J.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
    • (2001) N Engl J Med , vol.345 , pp. 1014-1021
    • de Lemos, J.A.1    Morrow, D.A.2    Bentley, J.H.3
  • 2
    • 42949169040 scopus 로고    scopus 로고
    • Pro-B-type natriuretic peptide levels in acute decompensated heart failure
    • Waldo S.W., Beede J., Isakson S., et al. Pro-B-type natriuretic peptide levels in acute decompensated heart failure. J Am Coll Cardiol 51 (2008) 1874-1882
    • (2008) J Am Coll Cardiol , vol.51 , pp. 1874-1882
    • Waldo, S.W.1    Beede, J.2    Isakson, S.3
  • 3
    • 0347625843 scopus 로고    scopus 로고
    • B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study
    • Bibbins-Domingo K., Ansari M., Schiller N.B., Massie B., and Whooley M.A. B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study. Circulation 108 (2003) 2987-2992
    • (2003) Circulation , vol.108 , pp. 2987-2992
    • Bibbins-Domingo, K.1    Ansari, M.2    Schiller, N.B.3    Massie, B.4    Whooley, M.A.5
  • 5
    • 44649155766 scopus 로고    scopus 로고
    • Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure
    • Nishii M., Inomata T., Takehana H., et al. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure. J Am Coll Cardiol 51 (2008) 2329-2335
    • (2008) J Am Coll Cardiol , vol.51 , pp. 2329-2335
    • Nishii, M.1    Inomata, T.2    Takehana, H.3
  • 6
    • 34247135389 scopus 로고    scopus 로고
    • Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study
    • Jourdain P., Jondeau G., Funck F., et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol 49 (2007) 1733-1739
    • (2007) J Am Coll Cardiol , vol.49 , pp. 1733-1739
    • Jourdain, P.1    Jondeau, G.2    Funck, F.3
  • 7
    • 1442265589 scopus 로고    scopus 로고
    • Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea
    • Mueller C., Scholer A., Laule-Kilian K., et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 350 (2004) 647-654
    • (2004) N Engl J Med , vol.350 , pp. 647-654
    • Mueller, C.1    Scholer, A.2    Laule-Kilian, K.3
  • 8
    • 0034176934 scopus 로고    scopus 로고
    • Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations
    • Troughton R.W., Frampton C.M., Yandle T.G., Espiner E.A., Nicholls M.G., and Richards A.M. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 355 (2000) 1126-1130
    • (2000) Lancet , vol.355 , pp. 1126-1130
    • Troughton, R.W.1    Frampton, C.M.2    Yandle, T.G.3    Espiner, E.A.4    Nicholls, M.G.5    Richards, A.M.6
  • 9
    • 66349111734 scopus 로고    scopus 로고
    • Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association
    • Hlatky M.A., Greenland P., Arnett D.K., et al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 119 (2009) 2408-2416
    • (2009) Circulation , vol.119 , pp. 2408-2416
    • Hlatky, M.A.1    Greenland, P.2    Arnett, D.K.3
  • 10
    • 70349742449 scopus 로고    scopus 로고
    • Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery?. A systematic review and meta-analysis of observational studies
    • Karthikeyan G., Moncur R.A., Levine O., et al. Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery?. A systematic review and meta-analysis of observational studies. J Am Coll Cardiol 54 (2009) 1599-1606
    • (2009) J Am Coll Cardiol , vol.54 , pp. 1599-1606
    • Karthikeyan, G.1    Moncur, R.A.2    Levine, O.3
  • 11
    • 53749094306 scopus 로고    scopus 로고
    • A meta-analysis of the utility of pre-operative brain natriuretic peptide in predicting early and intermediate-term mortality and major adverse cardiac events in vascular surgical patients
    • Rodseth R.N., Padayachee L., and Biccard B.M. A meta-analysis of the utility of pre-operative brain natriuretic peptide in predicting early and intermediate-term mortality and major adverse cardiac events in vascular surgical patients. Anaesthesia 63 (2008) 1226-1233
    • (2008) Anaesthesia , vol.63 , pp. 1226-1233
    • Rodseth, R.N.1    Padayachee, L.2    Biccard, B.M.3
  • 12
    • 63849319173 scopus 로고    scopus 로고
    • A preliminary report on the prognostic significance of preoperative brain natriuretic peptide and postoperative cardiac troponin in patients undergoing major vascular surgery
    • Bolliger D., Seeberger M.D., Lurati Buse G.A., et al. A preliminary report on the prognostic significance of preoperative brain natriuretic peptide and postoperative cardiac troponin in patients undergoing major vascular surgery. Anesth Analg 108 (2009) 1069-1075
    • (2009) Anesth Analg , vol.108 , pp. 1069-1075
    • Bolliger, D.1    Seeberger, M.D.2    Lurati Buse, G.A.3
  • 13
    • 33750353355 scopus 로고    scopus 로고
    • Assessment of cardiac risk before non-cardiac surgery: brain natriuretic peptide in 1590 patients
    • Dernellis J., and Panaretou M. Assessment of cardiac risk before non-cardiac surgery: brain natriuretic peptide in 1590 patients. Heart 92 (2006) 1645-1650
    • (2006) Heart , vol.92 , pp. 1645-1650
    • Dernellis, J.1    Panaretou, M.2
  • 14
    • 2342488799 scopus 로고    scopus 로고
    • Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial
    • discussion 975-6
    • Durazzo A.E., Machado F.S., Ikeoka D.T., et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 39 (2004) 967-975 discussion 975-6
    • (2004) J Vasc Surg , vol.39 , pp. 967-975
    • Durazzo, A.E.1    Machado, F.S.2    Ikeoka, D.T.3
  • 15
    • 67651155597 scopus 로고    scopus 로고
    • Reducing cardiac risk in non-cardiac surgery: evidence from the DECREASE studies (abstr)
    • Poldermans D., Schouten O., Bax J.J., and Winkel T.A. Reducing cardiac risk in non-cardiac surgery: evidence from the DECREASE studies (abstr). Eur Heart J 11 Suppl (2009) A9-A14
    • (2009) Eur Heart J , vol.11 , Issue.SUPPL
    • Poldermans, D.1    Schouten, O.2    Bax, J.J.3    Winkel, T.A.4
  • 16
    • 44349168172 scopus 로고    scopus 로고
    • Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial
    • Devereaux P.J., Yang H., Yusuf S., et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 371 (2008) 1839-1847
    • (2008) Lancet , vol.371 , pp. 1839-1847
    • Devereaux, P.J.1    Yang, H.2    Yusuf, S.3
  • 17
    • 0033540018 scopus 로고    scopus 로고
    • The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery
    • Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group
    • Poldermans D., Boersma E., Bax J.J., et al., Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 341 (1999) 1789-1794
    • (1999) N Engl J Med , vol.341 , pp. 1789-1794
    • Poldermans, D.1    Boersma, E.2    Bax, J.J.3
  • 18
    • 35248886065 scopus 로고    scopus 로고
    • ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery)
    • Fleisher L.A., Beckman J.A., Brown K.A., et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 50 (2007) 1707-1732
    • (2007) J Am Coll Cardiol , vol.50 , pp. 1707-1732
    • Fleisher, L.A.1    Beckman, J.A.2    Brown, K.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.